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a b s t r a c t
In this discussion paper, the transition from long-chain poly- and perﬂuorinated alkyl substances
(PFASs) to ﬂuorinated alternatives is addressed. Long-chain PFASs include perﬂuoroalkyl carboxylic
acids (PFCAs) with 7 or more perﬂuorinated carbons, perﬂuoroalkyl sulfonic acids (PFSAs) with 6
or more perﬂuorinated carbons, and their precursors. Because long-chain PFASs have been found
to be persistent, bioaccumulative and toxic, they are being replaced by a wide range of ﬂuorinated
alternatives. We summarize key concerns about the potential impacts of ﬂuorinated alternatives on
human health and the environment in order to provide concise information for different
stakeholders and the public. These concerns include, amongst others, the likelihood of ﬂuorinated
alternatives or their transformation products becoming ubiquitously present in the global environ-
ment; the need for more information on uses, properties and effects of ﬂuorinated alternatives;
the formation of persistent terminal transformation products including PFCAs and PFSAs; increasing
environmental and human exposure and potential of adverse effects as a consequence of the high
ultimate persistence and increasing usage of ﬂuorinated alternatives; the high societal costs that
would be caused if the uses, environmental fate, and adverse effects of ﬂuorinated alternatives
had to be investigated by publicly funded research; and the lack of consideration of non-persistent
alternatives to long-chain PFASs.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Helsingør Statement on poly- and perﬂuorinated alkyl
substances (PFASs)
We as scientists working on the characterization of the uses,
properties, analysis, environmental distribution and adverse
effects of poly- and perﬂuorinated alkyl substances, PFASs, are con-
cerned that long-chain PFASs are being replaced by a wide range of
ﬂuorinated alternatives for which we have only little information
on production volumes, uses, properties and biological effects.
Nevertheless, we do know that these replacements will be
similarly resistant to ultimate degradation, i.e. persistent, in the
environment as long-chain PFASs (Scheringer et al., 2013;
Strempel et al., 2012).
By long-chain PFASs we denote perﬂuoroalkyl carboxylic acids
(PFCAs) with 7 or more perﬂuorinated carbons, perﬂuoroalkyl
sulfonic acids (PFSAs) with 6 or more perﬂuorinated carbons, and
their precursors such as ﬂuorotelomer-based substances with 8
or more perﬂuorinated carbons and perﬂuoroalkane sulfonyl
ﬂuoride-based substances with 6 or more perﬂuorinated carbons.
The terminology for nomenclature of PFASs used herein has been
proposed by Buck et al. (2011).
In the absence of clear evidence that the alternatives are a sub-
stantial improvement on long-chain PFASs, we think that it is not
sufﬁcient that the substitution process of long-chain PFASs leads
to just an incremental shift in the type of products that are placed
on the global market and will be used by millions of consumers
and professional users. In this situation, we would like to bring
the following statement to the attention of policy makers and
various relevant stakeholders.
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1. PFASs are ubiquitous.
A wide range of PFASs, including ﬂuorinated alternatives to
long-chain PFASs, is present in environmental matrices (Giesy
and Kannan, 2002; McLachlan et al., 2007; Ahrens, 2011; Li et al.,
2011; Eschauzier et al., 2012; Müller et al., 2012; Zhao et al.,
2012; Gawor et al., 2013; Wang et al., 2013; Zareitalabad et al.,
2013), wildlife (Giesy and Kannan, 2002; Houde et al., 2011), and
human tissue (Giesy and Kannan, 2002; Kannan et al., 2004;
Martin et al., 2010; Kato et al., 2011; Loi et al., 2013; Yeung
et al., 2013a,b) all over the globe.
2. Regulation has caused levels of some PFAS to decline, but
others remain stable or continue to increase.
Because perﬂuorooctane sulfonic acid (PFOS), perﬂuorooctanoic
acid (PFOA), and PFCAs with 11–14 perﬂuorinated carbons have
been shown to be highly persistent and also bioaccumulative and
toxic, these substances are now regulated in the EU and Canada
and there have been several voluntary actions by the manufactur-
ing industry to phase out or reduce the emissions of these
substances (EU, 2006; Canada Gazette, 2013; ECHA, 2014; US
EPA, 2006); PFOS is also regulated globally under the Stockholm
Convention on Persistent Organic Pollutants (UNEP, 2014). These
regulations were established already after a decade of intense
scientiﬁc research. As a consequence of phase-out actions and reg-
ulations, levels of PFOS and PFOA in human blood samples have
now declined in many Western countries (Glynn et al., 2012;
Kato et al., 2011; Harada et al., 2010; Yeung et al., 2013a).
However, PFCAs with longer perﬂuorinated chains than PFOA, with
8 or more perﬂuoroalkyl carbons, have not yet shown signs of
decline in human blood samples globally (Kato et al., 2011;
Glynn et al., 2012; Yeung et al., 2013b).
3. More information on ﬂuorinated alternatives is urgently
needed.
Currently, a wide range of ﬂuorinated alternatives to long-chain
PFASs are being developed and commercialized (OECD, 2013;
Wang et al., 2013). Many of these ﬂuorinated alternatives are
shorter-chain homologues of long-chain PFASs (typically with 6
or fewer perﬂuoroalkyl carbons). This has the advantage of making
the substances less bioaccumulative than long-chain PFASs, but the
perﬂuorinated chain is still recalcitrant to degradation. Moreover,
shorter-chain alternatives are not always less bioaccumulative;
there is evidence of higher uptake into maize shoots compared to
long-chain PFASs (Krippner et al., 2014). In many cases there is
only very limited knowledge in the public domain on the struc-
tures, properties, uses and toxicological proﬁles of ﬂuorinated
alternatives. The levels of some ﬂuorinated alternatives or their
degradation products, such as perﬂuorobutane sulfonic acid (PFBS)
or perﬂuorobutanoic acid (PFBA), have been shown to be rising in
recent years in the environment and human tissues in Europe
(Glynn et al., 2012; Ahrens, 2011; Kirchgeorg et al., 2013). There
is an urgent need to provide the necessary knowledge on the
environmental and human health risks of this rapidly expanding
range of ﬂuorinated compounds, in a way that makes the informa-
tion publicly accessible.
4. Less efﬁcient ﬂuorinated alternatives may lead to increased
use, emissions, and exposure.
While the shorter-chain PFASs are being introduced because
they are generally less bioaccumulative, in some cases their techni-
cal performance is lower (Renner, 2006; Daikin, 2009; Archroma,
2013) and so there is a concern that larger quantities and/or more
substances will need to be used to provide the same performance,
potentially cancelling out the beneﬁt of lower bioaccumulation
potential.
5. Concerns about low testing requirements.
In the EU the testing requirements under REACH are deﬁned by
the production volume of a chemical. In cases where mixtures or
combinations of ﬂuorinated alternatives are used to replace a sin-
gle long-chain PFAS, the amounts of the individual substances may
be smaller than the amount of the long-chain PFAS to be replaced
so that also the testing requirements are lower. Furthermore, we
are concerned that current testing requirements are not sufﬁcient
to identify effects such as immunotoxicity and endocrine disrup-
tion, which have been linked to PFAS exposure (Grandjean and
Budtz-Jørgensen, 2013; White et al., 2011).
6. Regulations need to be established in an increasing number
of countries producing and applying PFASs.
PFASs including ﬂuorinated alternatives are manufactured by
an increasing number of producers and in more and more regions
of the world. As a consequence, the regulation of PFASs needs to be
implemented in more countries than in the past. The types of prod-
ucts available on the global market are also more diverse and dif-
ﬁcult to characterize.
7. PFASs, including ﬂuorinated alternatives, lead to highly
persistent transformation products, which implies increasing
human and environmental exposure.
In spite of the diversity of the ﬂuorinated alternatives, current
knowledge demonstrates that the perﬂuorinated parts of ﬂuori-
nated alternatives are recalcitrant and will form terminal transfor-
mation products, including PFCAs and PFSAs (Lee et al., 2010;
Young and Mabury, 2010; Liu and Mejia Avendaño, 2013; Butt
et al., 2014), which are persistent in the environment (Hurley
et al., 2004; Liou et al., 2010; Vaalgamaa et al., 2011; Liu et al.,
2013). Extensive and increasing use and emissions of ﬂuorinated
alternatives will lead to increasing levels of PFCAs, PFSAs and other
stable perﬂuorinated degradation products in the environment,
biota and humans.
8. Increasing exposure implies increasing risk of adverse effects.
It is therefore likely that the ﬂuorinated alternatives or their
transformation products will lead to large-scale environmental
and human exposure to a range of PFASs and possibly result in
adverse effects caused by these substances. As a consequence, we
are concerned that the current introduction of ﬂuorinated alterna-
tives eventually may lead to similar problems as occurred in the
cases of PFOS and long-chain PFCAs. If the highly persistent and
environmentally mobile ﬂuorinated alternatives are shown to
cause adverse effects in the future, it may take decades to reverse
global contamination to safe levels.
9. It is costly for society to produce new toxicological data;
therefore data produced by chemical manufacturers should be
made publicly available.
It would be an expensive and time-consuming process to initi-
ate years of publicly funded research into the properties and
potential effects of the ﬂuorinated alternatives. Therefore, all data
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on the chemical and toxicological properties of ﬂuorinated alterna-
tives collected by manufacturers and suppliers that are not cur-
rently publicly available should be made accessible. In addition
to the cost to society of publicly funded risk assessment, there is
the risk that there will be an irreversible global environmental
problem caused by the widespread occurrence of these ﬂuorinated
alternatives and/or their transformation products.
10. Non-persistent alternatives to long-chain PFASs should be
used to protect clean food and water resources for a growing
human population.
The goal should be to introduce non-persistent alternatives that
can be fully degraded and mineralized, and this may imply non-
ﬂuorinated products. Therefore, development of non-persistent
alternatives should be strongly encouraged and PFASs should only
be used in applications where they are truly needed and proven
indispensable.
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